Aadi Bioscience (NASDAQ:AADI - Get Free Report) is projected to announce its earnings results before the market opens on Wednesday, March 12th. Analysts expect the company to announce earnings of ($0.31) per share and revenue of $7.45 million for the quarter.
Aadi Bioscience Price Performance
NASDAQ:AADI traded up $0.02 during mid-day trading on Friday, reaching $2.12. 58,306 shares of the company's stock traded hands, compared to its average volume of 247,994. Aadi Bioscience has a 12-month low of $1.21 and a 12-month high of $3.81. The firm has a market capitalization of $52.36 million, a price-to-earnings ratio of -0.93 and a beta of 0.68. The company has a 50 day moving average price of $2.87 and a 200-day moving average price of $2.37.
Aadi Bioscience Company Profile
(
Get Free Report)
Aadi Bioscience, Inc, a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa.
Further Reading
Before you consider Aadi Bioscience, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aadi Bioscience wasn't on the list.
While Aadi Bioscience currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
